(Q46832072)

English

The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers.

scientific article published in October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

based on heuristic

inferred from title

prostate carcinoma

1 reference

based on heuristic

inferred from title

zoledronic acid

1 reference

based on heuristic

inferred from title

Alessandra Casuccio

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Fulfaro F

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Leto G

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Badalamenti G

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Arcara C

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Cicero G

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Valerio MR

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Di Fede G

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Russo A

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Vitale A

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Rini GB

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Intrivici C

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Gebbia N

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Journal of Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

555-559

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323446%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

Preclinical pharmacology of CGP 42'446, a new, potent, heterocyclic bisphosphonate compound

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

A systematic review of the role of bisphosphonates in metastatic disease

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

Effect of oral clodronate on bone pain. A controlled study in patients with metastic prostatic cancer

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

Combined analysis of two multicenter, randomized, placebo-controlled studies of pamidronate disodium for the palliation of bone pain in men with metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

Chemical and biological prerequisites for novel bisphosphonate molecules: results of comparative preclinical studies

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

Markers of bone turnover in bone metastases

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

Biochemical markers and skeletal metastases

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

Markers of bone turnover in prostate cancer

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2005.17.5.555

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46832072&oldid=1516351456"